Nadunolimab

DB18249InvestigationalProtein Based Therapies

Nadunolimab: Overview.

Mechanism: Pharmacologically active on Interleukin-1 receptor accessory protein
Curator reviewed
Code names: CAN04

Resolves to

Compound

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Nadunolimab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.